Clinical Endocannabinoid Deficiency

Clinical Endocannabinoid Deficiency (CECD) is a theory suggesting that some individuals may have lower levels or function of the body’s natural cannabinoids—compounds involved in regulating mood, pain, sleep, and inflammation. When these endocannabinoids are deficient, it might contribute to conditions like migraines, fibromyalgia, or irritable bowel syndrome. Think of it as a disrupted communication system within the body’s internal network, affecting overall balance and health. While research continues, CECD highlights the importance of the endocannabinoid system and its potential role in certain health issues.